Analyze Glycans Up To 5X Faster than HILIC

Video

Obtaining high resolution glycan data has traditionally required patience. Typical analysis methods can take up to a full day. Not any longer. SCIEX Fast Glycan Labeling and Analysis delivers rapid glycan heterogeneity identification, capable of profiling your glycans in record time. Combining simplified sample preparation, rapid separations and automated glycan identification, you can make confident decisions quickly by running glycans up to five-times faster than HILIC.

Watch Now

8 Stories of Lab Safety Gone Wrong

List

Read about eight incidents from which we can all learn important lessons about lab safety.

Read more

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine

News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

Read more

Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

Read more
Edith Heard Unanimously Selected as Next Director General of EMBL

Edith Heard Unanimously Selected as Next Director General of EMBL

News

At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.

Read more
 
Large-Scale Production of Living Brain Cells Enables Entirely New Research
News

After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.

Read more

Agilent Technologies Presents Thought Leader Award to Dr. Ram Sasisekharan
News

Agilent Technologies awards Dr. Ram Sasisekharan with the Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization.

Read more

CRISPR Reveals New Targets for Promising Cancer Drugs
News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

Read more